Welcome to Show the Receipts, a series where we ask interesting people to share exactly how much it costs to get shit done.

China, which is the largest market for refractive procedures, had fluctuating demand in 2024, lowering Staar's performance, the company said. Low demand and weak consumer sentiment in China is ...

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses ...

STAAR Surgical (NASDAQ:STAA) reported its Q4 2024 earnings, revealing a significant miss on both earnings per share (EPS) and revenue compared to forecasts. The company posted an EPS of -$0.69, far ...